Zhejiang Wecome Pharmaceutical Company Limited (SHE:300878)

SHE:300878 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 11, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Market Capitalization	4,534	3,624	2,141	3,673	3,591	4,246
Market Cap Growth	113.08%	69.28%	-41.72%	2.30%	-15.42%	4.95%
Enterprise Value	4,595	3,642	2,172	3,685	3,506	3,996
Last Close Price	31.92	25.51	14.94	24.77	24.21	28.27
PE Ratio	-	-	-	-	73.57	44.00
PS Ratio	20.14	16.09	6.10	7.07	6.74	6.71
PB Ratio	4.90	3.92	1.82	2.61	2.55	3.01
P/TBV Ratio	5.14	4.12	1.92	2.77	2.69	3.17
P/OCF Ratio	86.07	54.01	-	63.02	24.73	-
EV/Sales Ratio	20.41	16.17	6.19	7.09	6.58	6.31
EV/EBITDA Ratio	-	-	-	137.76	41.71	40.93
EV/EBIT Ratio	-	-	-	-	64.63	47.80
Debt / Equity Ratio	0.26	0.18	0.25	0.31	0.23	0.06
Debt / EBITDA Ratio	30.42	-	-	16.27	3.30	0.74
Net Debt / Equity Ratio	0.05	0.02	0.03	-0.10	0.11	-0.14
Net Debt / EBITDA Ratio	-20.79	-0.77	-0.37	-5.25	1.86	-2.03
Net Debt / FCF Ratio	-29.34	-214.11	-0.25	1.73	-5.54	0.83
Asset Turnover	0.15	0.16	0.19	0.26	0.30	0.38
Inventory Turnover	1.56	1.73	1.64	1.91	1.78	1.93
Quick Ratio	1.59	1.61	1.96	1.95	2.09	2.98
Current Ratio	1.95	2.07	2.57	2.36	2.50	3.74
Return on Equity (ROE)	-20.89%	-21.91%	-11.22%	-0.50%	3.51%	6.91%
Return on Assets (ROA)	-2.83%	-3.69%	-5.44%	-0.63%	1.88%	3.15%
Return on Invested Capital (ROIC)	-6.93%	-7.95%	-13.03%	-1.40%	3.06%	8.01%
Return on Capital Employed (ROCE)	-6.20%	-8.00%	-11.40%	-1.20%	3.60%	5.70%
Earnings Yield	-4.76%	-6.27%	-6.89%	-0.24%	1.36%	2.27%
FCF Yield	-0.04%	-0.00%	-7.20%	-2.21%	-0.79%	-5.63%
Dividend Yield	0.44%	-	0.94%	1.01%	-	1.06%
Payout Ratio	-	-	-	-	93.71%	83.93%
Buyback Yield / Dilution	-0.99%	-1.17%	4.09%	-3.96%	0.32%	-19.60%
Total Shareholder Return	-0.55%	-1.17%	5.03%	-2.95%	0.32%	-18.53%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.